Skip to content

Corvus Pharmaceuticals CRVS Proceeds from disposals of property, plant and equipment

Proceeds from disposals of property, plant and equipment at other companies

TE Connectivity logo
TE ConnectivityTEL
$3M+200%
Hallador Energy logo
Hallador EnergyHNRG
$201K+857%
Johnson Controls International logo
Johnson Controls InternationalJCI
$9.25M+3,600%
NXP Semiconductors logo
NXP SemiconductorsNXPI
$0-100%
Willis Lease Finance logo
Willis Lease FinanceWLFC
$71.41M+49.6%
O'Reilly Automotive logo
O'Reilly AutomotiveORLY
$1.54M-20.8%

Other financials

Income statement

See full
Operating income-$14.9M-49.9%
Net income-$13.7M-190%
EPS (diluted)-$0.15-15.4%

Balance sheet

See full
Cash & equivalents$40.1M+702%
Total debt$834.0K-27.7%
Total equity$240.7M+388%
Total assets$253.2M+326%

Cash flow

See full
Operating cash flow-$10.4M-25.5%
CapEx$91.0K+153%
Free cash flow-$10.5M-26.1%

Valuation

See full
Market cap$1.1B+259%
Enterprise value$1.06B+251%

Returns & leverage

See full
Return on equity-30.5%-12.5pp
Debt / equity0.0×
Current ratio19.8×+14.9×

Where this comes from

Reported directly by Corvus Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment.

The official record: Corvus Pharmaceuticals’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Corvus Pharmaceuticals's proceeds from disposals of property, plant and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Corvus Pharmaceuticals's proceeds from disposals of property, plant and equipment?
Corvus Pharmaceuticals (CRVS) reported proceeds from disposals of property, plant and equipment of $1.25K in Q4 2024.